Nisa Investment Advisors’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $21.4K | Buy |
+1,846
| New | +$21.4K | ﹤0.01% | 1906 |
|
2025
Q1 | – | Sell |
-16,500
| Closed | -$237K | – | 3061 |
|
2024
Q4 | $237K | Buy |
+16,500
| New | +$237K | ﹤0.01% | 1246 |
|
2024
Q2 | – | Sell |
-28,200
| Closed | -$1.06M | – | 2975 |
|
2024
Q1 | $1.06M | Hold |
28,200
| – | – | 0.01% | 867 |
|
2023
Q4 | $1.58M | Hold |
28,200
| – | – | 0.01% | 725 |
|
2023
Q3 | $1.16M | Hold |
28,200
| – | – | 0.01% | 825 |
|
2023
Q2 | $1.57M | Hold |
28,200
| – | – | 0.01% | 739 |
|
2023
Q1 | $1.57M | Hold |
28,200
| – | – | 0.01% | 722 |
|
2022
Q4 | $1.03M | Buy |
+28,200
| New | +$1.03M | 0.01% | 905 |
|
2022
Q3 | – | Sell |
-16,600
| Closed | -$751K | – | 2638 |
|
2022
Q2 | $751K | Buy |
16,600
+12,800
| +337% | +$579K | 0.01% | 917 |
|
2022
Q1 | $289K | Buy |
+3,800
| New | +$289K | ﹤0.01% | 1238 |
|
2021
Q4 | – | Sell |
-900
| Closed | -$131 | – | 2326 |
|
2021
Q3 | $131 | Sell |
900
-22,338
| -96% | -$3.25K | ﹤0.01% | 1583 |
|
2021
Q2 | $4.55K | Buy |
23,238
+18,600
| +401% | +$3.64K | 0.03% | 472 |
|
2021
Q1 | $839 | Hold |
4,638
| – | – | 0.01% | 1028 |
|
2020
Q4 | $657K | Buy |
4,638
+2,655
| +134% | +$376K | ﹤0.01% | 1077 |
|
2020
Q3 | $247K | Buy |
+1,983
| New | +$247K | ﹤0.01% | 1255 |
|